Androgen Receptor Signaling in Salivary Gland Cancer
AbstractSalivary gland cancers comprise a small subset of human malignancies, and are classified into multiple subtypes that exhibit diverse histology, molecular biology and clinical presentation. Local disease is potentially curable with surgery, which may be combined with adjuvant radiotherapy. However, metastatic or unresectable tumors rarely respond to chemotherapy and carry a poorer prognosis. Recent molecular studies have shown evidence of androgen receptor signaling in several types of salivary gland cancer, mainly salivary duct carcinoma. Successful treatment with anti-androgen therapy in other androgen receptor-positive malignancies such as prostate and breast cancer has inspired researchers to investigate this treatment in salivary gland cancer as well. In this review, we describe the prevalence, biology, and therapeutic implications of androgen receptor signaling in salivary gland cancer. View Full-Text
Share & Cite This Article
Dalin, M.G.; Watson, P.A.; Ho, A.L.; Morris, L.G.T. Androgen Receptor Signaling in Salivary Gland Cancer. Cancers 2017, 9, 17.
Dalin MG, Watson PA, Ho AL, Morris LGT. Androgen Receptor Signaling in Salivary Gland Cancer. Cancers. 2017; 9(2):17.Chicago/Turabian Style
Dalin, Martin G.; Watson, Philip A.; Ho, Alan L.; Morris, Luc G.T. 2017. "Androgen Receptor Signaling in Salivary Gland Cancer." Cancers 9, no. 2: 17.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.